Key Takeaway
GLP-1 results after 3 weeks across all medications. Compares steady-state effects, weight trends, and dose-increase preparation for semaglutide, tirzepatide, and liraglutide.
GLP-1 results after 3 weeks put you near the end of the introductory phase for every major medication in this class. If you're on semaglutide, tirzepatide, or liraglutide, three weeks means your body has adapted to GLP-1 receptor stimulation, side effects have resolved, and you're approaching your first dose increase. This guide compares where you stand across all GLP-1 options and outlines what the next phase brings.
3-Week Comparison Table
| Medication | Dose at Week 3 | Cumulative Weight Loss | Appetite Effect | Next Increase |
|---|---|---|---|---|
| Semaglutide (Ozempic/Wegovy) | 0.25 mg | 1-5 lbs | Mild, stable | 0.5 mg at week 5 |
| Tirzepatide (Mounjaro/Zepbound) | 2.5 mg | 2-7 lbs | Moderate, stable | 5 mg at week 5 |
| Liraglutide (Saxenda) | 1.8 mg | 1-4 lbs | Mild | 2.4 mg at week 4 |
| Compounded Semaglutide | 0.25 mg (typical) | 1-5 lbs | Mild, stable | 0.5 mg at week 5 |
Note that liraglutide (Saxenda) follows a daily dosing schedule with weekly increases, so at week 3 it's already at a higher relative dose. But liraglutide produces less total weight loss than semaglutide or tirzepatide over the full treatment course. GLP-1 medications compared
The Steady-State Sweet Spot
At week 3, all once-weekly GLP-1 medications are at or near steady state at their introductory dose. This is a useful checkpoint because it tells you exactly what the starting dose can and can't do:
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
What Steady State at Starting Dose Does
- Mild but consistent appetite reduction
- Resolved GI side effects (your body has adapted)
- Modest blood sugar improvements for diabetes patients
- A new baseline eating pattern with slightly smaller portions
What It Can't Do
- Produce significant ongoing weight loss (the dose is too low)
- Achieve target HbA1c for most diabetes patients
- Produce the dramatic appetite suppression that comes at therapeutic doses
- Match the results you see in clinical trial headlines (those are at maximum doses over 12-18 months)
What to Focus on in the Final Week Before Escalation
You have 1-2 weeks before your first dose increase. Use this time wisely:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Lock In Your Habits
- Protein routine: Verify you're consistently hitting 75-100g daily. This becomes non-negotiable at higher doses when you eat less
- Hydration: 64-80 oz of water daily should be automatic by now
- Exercise: Resistance training 2-3x/week plus daily walking. These habits compound massively over the coming months
- Sleep: 7-8 hours nightly. Poor sleep undermines appetite regulation and weight loss
Prepare Your Kitchen
At higher doses, cooking large meals may feel less appealing because your appetite will be significantly reduced. Stock up on convenient, protein-rich options: rotisserie chicken, Greek yogurt, hard-boiled eggs, protein shakes, pre-portioned meals.
Prepare Mentally
The first dose increase may bring a brief return of mild nausea (usually 2-4 days). It's typically less severe than what you felt when starting. Having realistic expectations prevents unnecessary anxiety.
Frequently Asked Questions
My weight hasn't changed since week 1. Should I switch medications?
Absolutely not. Three weeks at an introductory dose tells you nothing about your eventual response. Weight loss stalls at the starting dose are universal. Evaluate your medication choice after 8-12 weeks at therapeutic doses.
Will the dose increase make me sick?
Most patients experience only mild, brief nausea when increasing. Eating smaller meals, avoiding greasy foods, and staying hydrated minimize the impact. Severe side effects at dose increases are uncommon in patients who tolerated the starting dose well.
Is 3 weeks enough to know if I am tolerating the medication?
Yes. Three weeks at the starting dose is an excellent tolerability test. If you have managed well at this dose with resolved or minimal side effects, you're very likely to tolerate the next dose level too. GLP-1 dose escalation
When should I get lab work done?
Most providers check labs at baseline (before starting) and again at 12 weeks. The 3-week mark is too early for meaningful HbA1c or lipid changes. If you haven't had baseline labs drawn yet, get them now so you have a comparison point. GLP-1 monitoring labs
The Acceleration Is Coming
Three weeks in, and you have proven you can tolerate GLP-1 therapy. The next phase, starting with your first dose increase, is where the real transformation begins. Patients who have consistent habits heading into the escalation phase see the best outcomes over 6-12 months.
At FormBlends, we prepare you for each dose transition and track your response closely.
Ready for the next level? Connect with our clinical team for personalized dose-transition support.